367
ALX Oncology Holdings Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
271
FY23:
189
FY24:
134
FY25:
50.7
(positive)
Change from FY21 to FY25
millions USD
FY21:
13.2
FY22:
35.5
FY23:
53.9
FY24:
13.4
FY25:
8.32
Total assets
Change from FY21 to FY25
millions USD
FY21:
380
FY22:
306
FY23:
243
FY24:
148
FY25:
59.0
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
15.3
FY22:
28.3
FY23:
36.0
FY24:
18.5
FY25:
24.6
(negative)
Change from FY21 to FY25
millions USD
FY21:
1.84
FY22:
14.7
FY23:
16.8
FY24:
15.7
FY25:
8.51
(positive)
Change from FY21 to FY25
millions USD
FY21:
363
FY22:
263
FY23:
190
FY24:
114
FY25:
26.0
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
380
FY22:
306
FY23:
243
FY24:
148
FY25:
59.0
All amounts in millions USD